Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide ; volume:8 ; number:2 ; day:3 ; month:10 ; year:2011 ; pages:1 ; date:12.2011
Retrovirology ; 8, Heft 2 (3.10.2011), 1, 12.2011
- Urheber
-
Férir, Geoffrey
- Beteiligte Personen und Organisationen
-
Palmer, Kenneth E.
Schols, Dominique
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-8-S2-O36
- URN
-
urn:nbn:de:1111-2016080720144
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Férir, Geoffrey
- Palmer, Kenneth E.
- Schols, Dominique
- SpringerLink (Online service)
Ähnliche Objekte (12)
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance
Anti-HIV activity of drugs that stimulate cholesterol efflux
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance
Anti-HIV activity of drugs that stimulate cholesterol efflux
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study
Model-based anti-HIV therapy
Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood
The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Dual anti-HIV mechanism of clofarabine
Universal access to anti-HIV therapy
Anti-HIV nucleosides : past, present and future
Anti-HIV and immune modulating activities of IND02
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Semi-supervised learning for predicting anti-HIV drug resistance